Roivant Sciences Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	1,419	2,715	6,495	1,677	2,060
Short-Term Investments	2,873	2,171	-	-	-
Cash & Short-Term Investments	4,292	4,887	6,495	1,677	2,060
Cash Growth	-12.18%	-24.76%	287.34%	-18.62%	0.26%
Other Receivables	770.24	-	-	-	-
Total Trade Receivables	770.24	-	-	-	-
Other Current Assets	105.32	113.17	236.88	121.77	86.12
Total Current Assets	5,167	5,000	6,732	1,799	2,147
Net Property, Plant & Equipment	92.4	101.08	59.32	92.34	86.95
Other Intangible Assets	-	-	-	144.88	-
Long-Term Investments	407.99	302.94	247.75	304.32	325.83
Other Long-Term Assets	40.92	32.86	183.58	49.48	25.82
Total Assets	5,709	5,437	7,222	2,390	2,585
Accounts Payable	18	23.69	14.03	37.83	34.58
Accrued Expenses	251.51	114.71	119.42	167.13	127.53
Current Portion of Long-Term Debt	-	-	-	40.72	-
Current Portion of Leases	11.15	9.84	8.97	11.69	11.4
Other Current Liabilities	0.58	1.17	124.35	15.08	10.86
Total Current Liabilities	281.24	149.41	266.76	272.45	184.37
Long-Term Debt	-	-	-	375.52	210.03
Long-Term Leases	96.29	90.33	45.02	53.48	62.47
Other Long-Term Liabilities	38.74	10	462.18	80.58	66.84
Total Long-Term Liabilities	135.03	100.33	507.2	509.57	339.33
Total Liabilities	416.28	249.74	773.95	782.02	523.7
Additional Paid-in Capital	5,025	4,562	5,396	4,933	4,422
Accumulated Other Comprehensive Income	4.36	9.44	-4.08	-2.62	-0.95
Retained Earnings	-501.81	116.06	576.17	-3,773	-2,764
Total Common Shareholders' Equity	4,527	4,688	5,969	1,158	1,657
Minority Interest	765.04	499.59	479.95	449.82	404.49
Shareholders' Equity	5,292	5,187	6,449	1,608	2,061
Total Liabilities & Equity	5,709	5,437	7,222	2,390	2,585
Total Debt	107.44	100.17	53.99	481.4	283.89
Net Cash (Debt)	4,184	4,787	6,441	1,195	1,777
Net Cash Growth	-12.58%	-25.68%	438.81%	-32.71%	-1.85%
Net Cash Per Share	6.03	6.60	7.75	1.68	2.65
Book Value	4,527	4,688	5,969	1,158	1,657
Book Value Per Share	6.52	6.46	7.18	1.62	2.47
Tangible Book Value	4,527	4,688	5,969	1,013	1,657
Tangible Book Value Per Share	6.52	6.46	7.18	1.42	2.47

Updated May 21, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q